+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

BCG Vaccine Market Size, Share & Trends Analysis Report 2026-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2026
  • Region: Global
  • Grand View Research
  • ID: 6285278
REQUEST CUSTOMIZATION
Description Jump to:
The global BCG vaccine market size was valued at USD 181.8 million in 2025 and is projected to grow from USD 190.3 million in 2026 to USD 275.5 million by 2033, at a CAGR of 5.4% from 2026 to 2033. Asia Pacific dominated the market, accounting for the largest share of 47.8% in 2025. The industry is supported by the continued use of the Bacillus Calmette-Guérin (BCG) vaccine for tuberculosis (TB) prevention and the treatment of non-muscle invasive bladder cancer.

The vaccine is included in national immunization programs in many countries with a moderate to high TB burden, especially across Asia Pacific, Africa, and parts of Latin America. Government vaccination programs and procurement by public health agencies continue to support market demand. The market has a limited number of manufacturers, making supply dependent on production capacity, regulatory compliance, and quality standards. Manufacturers are investing in production upgrades and capacity expansion to improve product availability. Research on new therapeutic uses of BCG is ongoing, but its primary use remains TB prevention and bladder cancer treatment. Support from global health organizations, continued focus on tuberculosis control, and stable demand from public healthcare systems continue to maintain the market across developed and developing countries.

Global BCG Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global BCG vaccine market report based on product, distribution channel, and region:

Product Outlook (Revenue, USD Million, 2021 - 2033)

  • Immune BCG Vaccine
  • Therapeutic BCG Vaccine

Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

  • Public Sector
  • Private Sector

Regional Outlook (Revenue, USD Million, 2021 - 2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. The internal database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. BCG Vaccine Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. BCG Vaccine Market: Product Business Analysis
4.1. Product Market Share, 2025 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, Product, 2021 to 2033 (USD Million)
4.4. Immune BCG Vaccine
4.4.1. Immune BCG Vaccine Market, 2021 - 2033 (USD Million)
4.5. Therapeutic BCG Vaccine
4.5.1. Therapeutic BCG Vaccine Market, 2021 - 2033 (USD Million)
Chapter 5. BCG Vaccine Market: Distribution Channel Business Analysis
5.1. Distribution Channel Market Share, 2025 & 2033
5.2. Distribution Channel Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, Distribution Channel, 2021 to 2033 (USD Million)
5.4. Public Sector
5.4.1. Public Sector Market, 2021 - 2033 (USD Million)
5.5. Private Sector
5.5.1. Private Sector Market, 2021 - 2033 (USD Million)
Chapter 6. BCG Vaccine Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2025 & 2033
6.2. Regional Market Dashboard
6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
6.4. North America
6.4.1. North America BCG Vaccine Market Estimates and Forecasts, Country, 2021 - 2033 (USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Target Disease Prevalence
6.4.2.3. Regulatory Framework
6.4.2.4. Reimbursement Framework
6.4.2.5. U.S. BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Target Disease Prevalence
6.4.3.3. Regulatory Framework
6.4.3.4. Reimbursement Framework
6.4.3.5. Canada BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4.4. Mexico
6.4.4.1. Key Country Dynamics
6.4.4.2. Target Disease Prevalence
6.4.4.3. Regulatory Framework
6.4.4.4. Reimbursement Framework
6.4.4.5. Mexico BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Europe
6.5.1. Europe BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.2. UK
6.5.2.1. Key Country Dynamics
6.5.2.2. Target Disease Prevalence
6.5.2.3. Regulatory Framework
6.5.2.4. Reimbursement Framework
6.5.2.5. UK BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.3. Germany
6.5.3.1. Key Country Dynamics
6.5.3.2. Target Disease Prevalence
6.5.3.3. Regulatory Framework
6.5.3.4. Reimbursement Framework
6.5.3.5. Germany BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.4. France
6.5.4.1. Key Country Dynamics
6.5.4.2. Target Disease Prevalence
6.5.4.3. Regulatory Framework
6.5.4.4. Reimbursement Framework
6.5.4.5. France BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.5. Italy
6.5.5.1. Key Country Dynamics
6.5.5.2. Target Disease Prevalence
6.5.5.3. Regulatory Framework
6.5.5.4. Reimbursement Framework
6.5.5.5. Italy BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.6. Spain
6.5.6.1. Key Country Dynamics
6.5.6.2. Target Disease Prevalence
6.5.6.3. Regulatory Framework
6.5.6.4. Reimbursement Framework
6.5.6.5. Spain BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.7. Denmark
6.5.7.1. Key Country Dynamics
6.5.7.2. Target Disease Prevalence
6.5.7.3. Regulatory Framework
6.5.7.4. Reimbursement Framework
6.5.7.5. Denmark BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.8. Sweden
6.5.8.1. Key Country Dynamics
6.5.8.2. Target Disease Prevalence
6.5.8.3. Regulatory Framework
6.5.8.4. Reimbursement Framework
6.5.8.5. Sweden BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5.9. Norway
6.5.9.1. Key Country Dynamics
6.5.9.2. Target Disease Prevalence
6.5.9.3. Regulatory Framework
6.5.9.4. Reimbursement Framework
6.5.9.5. Norway BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6. Asia Pacific
6.6.1. Asia Pacific BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.2. Japan
6.6.2.1. Key Country Dynamics
6.6.2.2. Target Disease Prevalence
6.6.2.3. Regulatory Framework
6.6.2.4. Reimbursement Framework
6.6.2.5. Japan BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Target Disease Prevalence
6.6.3.3. Regulatory Framework
6.6.3.4. Reimbursement Framework
6.6.3.5. China BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.4. India
6.6.4.1. Key Country Dynamics
6.6.4.2. Target Disease Prevalence
6.6.4.3. Regulatory Framework
6.6.4.4. Reimbursement Framework
6.6.4.5. India BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Target Disease Prevalence
6.6.5.3. Regulatory Framework
6.6.5.4. Reimbursement Framework
6.6.5.5. Australia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.6. South Korea
6.6.6.1. Key Country Dynamics
6.6.6.2. Target Disease Prevalence
6.6.6.3. Regulatory Framework
6.6.6.4. Reimbursement Framework
6.6.6.5. South Korea BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.6.7. Thailand
6.6.7.1. Key Country Dynamics
6.6.7.2. Target Disease Prevalence
6.6.7.3. Regulatory Framework
6.6.7.4. Reimbursement Framework
6.6.7.5. Thailand BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7. Latin America
6.7.1. Latin America BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.2. Brazil
6.7.2.1. Key Country Dynamics
6.7.2.2. Target Disease Prevalence
6.7.2.3. Regulatory Framework
6.7.2.4. Reimbursement Framework
6.7.2.5. Brazil BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Target Disease Prevalence
6.7.3.3. Regulatory Framework
6.7.3.4. Reimbursement Framework
6.7.3.5. Argentina BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8. Middle East and Africa
6.8.1. Middle East and Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.2. South Africa
6.8.2.1. Key Country Dynamics
6.8.2.2. Target Disease Prevalence
6.8.2.3. Regulatory Framework
6.8.2.4. Reimbursement Framework
6.8.2.5. South Africa BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.3. Saudi Arabia
6.8.3.1. Key Country Dynamics
6.8.3.2. Target Disease Prevalence
6.8.3.3. Regulatory Framework
6.8.3.4. Reimbursement Framework
6.8.3.5. Saudi Arabia BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.4. UAE
6.8.4.1. Key Country Dynamics
6.8.4.2. Target Disease Prevalence
6.8.4.3. Regulatory Framework
6.8.4.4. Reimbursement Framework
6.8.4.5. UAE BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
6.8.5. Kuwait
6.8.5.1. Key Country Dynamics
6.8.5.2. Target Disease Prevalence
6.8.5.3. Regulatory Framework
6.8.5.4. Reimbursement Framework
6.8.5.5. Kuwait BCG Vaccine Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Merck & Co., Inc.
7.5.1.1. Overview
7.5.1.2. Financial Performance
7.5.1.3. Product Benchmarking
7.5.1.4. Strategic Initiatives
7.5.2. Serum Institute of India Pvt. Ltd.
7.5.2.1. Overview
7.5.2.2. Financial Performance
7.5.2.3. Product Benchmarking
7.5.2.4. Strategic Initiatives
7.5.3. Japan BCG Laboratory
7.5.3.1. Overview
7.5.3.2. Financial Performance
7.5.3.3. Product Benchmarking
7.5.3.4. Strategic Initiatives
7.5.4. AJ Vaccines A/S
7.5.4.1. Overview
7.5.4.2. Financial Performance
7.5.4.3. Product Benchmarking
7.5.4.4. Strategic Initiatives
7.5.5. China National Biotec Group (CNBG)
7.5.5.1. Overview
7.5.5.2. Financial Performance
7.5.5.3. Product Benchmarking
7.5.5.4. Strategic Initiatives
7.5.6. GreenSignal Bio Pharma Ltd.
7.5.6.1. Overview
7.5.6.2. Financial Performance
7.5.6.3. Product Benchmarking
7.5.6.4. Strategic Initiatives
7.5.7. InterVax Ltd.
7.5.7.1. Overview
7.5.7.2. Financial Performance
7.5.7.3. Product Benchmarking
7.5.7.4. Strategic Initiatives
7.5.8. BioFarma.
7.5.8.1. Overview
7.5.8.2. Financial Performance
7.5.8.3. Product Benchmarking
7.5.8.4. Strategic Initiatives
7.5.9. Biomed-Lublin S.A.
7.5.9.1. Overview
7.5.9.2. Financial Performance
7.5.9.3. Product Benchmarking
7.5.9.4. Strategic Initiatives
7.5.10. BB-NCIPD Ltd.
7.5.10.1. Overview
7.5.10.2. Financial Performance
7.5.10.3. Product Benchmarking
7.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global BCG vaccine market, region, 2021 - 2033 (USD Million)
Table 4 Global BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 5 Global BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 6 North America BCG vaccine market, country, 2021 - 2033 (USD Million)
Table 7 North America BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 8 North America BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 9 U.S. BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 10 U.S. BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 11 Canada BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 12 Canada BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 13 Mexico BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 14 Mexico BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 15 Europe BCG vaccine market, country, 2021 - 2033 (USD Million)
Table 16 Europe BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 17 Europe BCG vaccine market, distribution channel, 2021 - 2033 (USD Million)
Table 18 UK BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 19 UK BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 20 Germany BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 21 Germany BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 22 France BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 23 France BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 24 Italy BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 25 Italy BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 26 Spain BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 27 Spain BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 28 Norway BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 29 Norway BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 30 Denmark BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 31 Denmark BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 32 Sweden BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 33 Sweden BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 34 Asia Pacific BCG vaccine market, country, 2021 - 2033 (USD Million)
Table 35 Asia Pacific BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 36 Asia Pacific BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 37 Japan BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 38 Japan BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 39 China BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 40 China BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 41 India BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 42 India BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 43 Australia BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 44 Australia BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 45 South Korea BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 46 South Korea BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 47 Thailand BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 48 Thailand BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 49 Latin America BCG vaccine market, country, 2021 - 2033 (USD Million)
Table 50 Latin America BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 51 Latin America BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 52 Brazil BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 53 Brazil BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 54 Argentina BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 55 Argentina BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 56 Middle East & Africa BCG vaccine market, country, 2021 - 2033 (USD Million)
Table 57 Middle East & Africa BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 58 Middle East & Africa BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 59 South Africa BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 60 South Africa BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 61 Saudi Arabia BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 62 Saudi Arabia BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 63 UAE BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 64 UAE BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
Table 65 Kuwait BCG vaccine market, product, 2021 - 2033 (USD Million)
Table 66 Kuwait BCG vaccine market, distibution channel, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 BCG vaccine market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Competitive landscape
Figure 10 BCG vaccine market dynamics
Figure 11 BCG vaccine market: Porter’s five forces analysis
Figure 12 BCG vaccine market: PESTLE analysis
Figure 13 Product market, 2021 - 2033 (USD Million)
Figure 14 Immune BCG vaccine market, 2021 - 2033 (USD Million)
Figure 15 Therapeutic BCG vaccine market, 2021 - 2033 (USD Million)
Figure 16 Distribution Channel market, 2021 - 2033 (USD Million)
Figure 17 Public sector market, 2021 - 2033 (USD Million)
Figure 18 Private sector market, 2021 - 2033 (USD Million)
Figure 19 BCG vaccine market revenue, region
Figure 20 Regional marketplace: Key takeaways
Figure 21 North America BCG vaccine market, 2021 - 2033 (USD Million)
Figure 22 U.S. country dynamics
Figure 23 U.S. BCG vaccine market, 2021 - 2033 (USD Million)
Figure 24 Canada country dynamics
Figure 25 Canada BCG vaccine market, 2021 - 2033 (USD Million)
Figure 26 Mexico country dynamics
Figure 27 Mexico BCG vaccine market, 2021 - 2033 (USD Million)
Figure 28 Europe BCG vaccine market, 2021 - 2033 (USD Million)
Figure 29 UK country dynamics
Figure 30 UK BCG vaccine market, 2021 - 2033 (USD Million)
Figure 31 Germany country dynamics
Figure 32 Germany BCG vaccine market, 2021 - 2033 (USD Million)
Figure 33 France country dynamics
Figure 34 France BCG vaccine market, 2021 - 2033 (USD Million)
Figure 35 Italy country dynamics
Figure 36 Italy BCG vaccine market, 2021 - 2033 (USD Million)
Figure 37 Spain country dynamics
Figure 38 Spain BCG vaccine market, 2021 - 2033 (USD Million)
Figure 39 Norway country dynamics
Figure 40 Norway BCG vaccine market, 2021 - 2033 (USD Million)
Figure 41 Sweden country dynamics
Figure 42 Sweden BCG vaccine market, 2021 - 2033 (USD Million)
Figure 43 Denmark country dynamics
Figure 44 Denmark BCG vaccine market, 2021 - 2033 (USD Million)
Figure 45 Asia Pacific BCG vaccine market, 2021 - 2033 (USD Million)
Figure 46 Japan country dynamics
Figure 47 Japan BCG vaccine market, 2021 - 2033 (USD Million)
Figure 48 China country dynamics
Figure 49 China BCG vaccine market, 2021 - 2033 (USD Million)
Figure 50 India country dynamics
Figure 51 India BCG vaccine market, 2021 - 2033 (USD Million)
Figure 52 Australia country dynamics
Figure 53 Australia BCG vaccine market, 2021 - 2033 (USD Million)
Figure 54 South Korea country dynamics
Figure 55 South Korea BCG vaccine market, 2021 - 2033 (USD Million)
Figure 56 Thailand country dynamics
Figure 57 Thailand BCG vaccine market, 2021 - 2033 (USD Million)
Figure 58 Latin America BCG vaccine market, 2021 - 2033 (USD Million)
Figure 59 Brazil country dynamics
Figure 60 Brazil BCG vaccine market, 2021 - 2033 (USD Million)
Figure 61 Argentina country dynamics
Figure 62 Argentina BCG vaccine market, 2021 - 2033 (USD Million)
Figure 63 MEA BCG vaccine market, 2021 - 2033 (USD Million)
Figure 64 South Africa country dynamics
Figure 65 South Africa BCG vaccine market, 2021 - 2033 (USD Million)
Figure 66 Saudi Arabia country dynamics
Figure 67 Saudi Arabia BCG vaccine market, 2021 - 2033 (USD Million)
Figure 68 UAE country dynamics
Figure 69 UAE BCG vaccine market, 2021 - 2033 (USD Million)
Figure 70 Kuwait country dynamics
Figure 71 Kuwait BCG vaccine market, 2021 - 2033 (USD Million)
Figure 72 Company categorization
Figure 73 Company market position analysis
Figure 74 Strategic framework

Companies Mentioned

  • Merck & Co., Inc.
  • Serum Institute of India Pvt. Ltd.
  • Japan BCG Laboratory
  • AJ Vaccines A/S
  • China National Biotec Group (CNBG)
  • GreenSignal Bio Pharma Ltd.
  • InterVax Ltd.
  • BioFarma
  • Biomed-Lublin S.A.
  • BB-NCIPD Ltd.

Related Topics

Related Reports

Therapeutic BCG Vaccine Market - Global Forecast 2026-2032 - Product Image

Therapeutic BCG Vaccine Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
BCG Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

BCG Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
BCG Vaccine Market by Age Group, Application, Distribution Channel, and By Region - Product Image

BCG Vaccine Market by Age Group, Application, Distribution Channel, and By Region

  • Report
  • 200 Pages
  • Global
From
BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology - Product Image

BCG Vaccine Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology

  • Report
  • 96 Pages
  • Global
From
BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

BCG Vaccine - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.